Welcome to our dedicated page for Xylem SEC filings (Ticker: XYL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xylem Inc. filings document the regulatory disclosures of a public operating company focused on water solutions and resource management. Recent Form 8-K reports furnish quarterly and annual financial results, including press-release exhibits for orders, revenue, earnings measures and guidance-related disclosures.
Other Xylem filings record capital actions such as common-stock repurchase authorization, while definitive proxy materials cover governance, shareholder voting matters and executive compensation disclosures, including equity-award and pay-versus-performance information.
FRIEL ROBERT F reported acquisition or exercise transactions in this Form 4 filing.
Xylem Inc. director Robert F. Friel received an equity award in the form of 2,481 shares of common stock, reported as a grant of restricted stock units valued at $116.88 per share. After this award, he directly holds 38,706 shares, including amounts credited through dividend reinvestment.
The award was granted under the Xylem 2011 Omnibus Incentive Plan and is scheduled to vest in full on the trading day before the 2027 Annual Meeting of Shareholders. Friel has elected to defer settlement of this RSU award until his Separation from Service, meaning he will receive the underlying shares at that later time rather than at vesting.
ELLIS EARL RAY reported acquisition or exercise transactions in this Form 4 filing.
Xylem Inc. director Earl Ray Ellis reported receiving an award of 1,711 shares of common stock as restricted stock units valued at $116.88 per share. These RSUs are scheduled to vest in full on the trading day before the company’s 2027 Annual Meeting of Shareholders.
Ellis has elected to defer settlement of this RSU award until Separation of Service, meaning the actual share delivery is postponed until he leaves service. After this grant and dividend reinvestment adjustments, he now directly holds 6,038 shares of Xylem common stock.
Xylem Inc. senior vice president and chief accounting officer Geri-Michelle McShane reported an open-market sale and an option exercise involving the company’s common stock. She sold 4,269 shares at a weighted average price of $117.46 per share, with individual trades ranging from $117.42 to $118.17.
On the same date, she exercised stock options to acquire 3,147 shares of common stock at an exercise price of $86.76 per share, fully exhausting that option grant. After these transactions, she directly owns 3,605 shares of Xylem common stock.
Filer submitted a Form 144 notice for proposed sales of Common stock. The filing lists Fidelity Brokerage Services LLC as the selling broker and records multiple restricted‑stock vesting entries and an option‑related line. The excerpt shows the numeric entries 4272, 501457.48, and 237693493 alongside 05/07/2026 and NYSE.
Xylem Inc. director Jerome A. Peribere executed an open-market purchase of 1,210 shares of common stock at $116.61 per share through the Jerome A Peribere 2016 Revocable TR, an indirect ownership vehicle.
Following this transaction, his indirect holdings through the trust total 27,209 common shares, while a separate line shows 4,036 common shares held directly. The scale of the purchase is modest relative to his overall reported position, indicating a routine addition rather than a transformational change in ownership.
Xylem Inc. ownership disclosed: Vanguard Capital Management reports beneficial ownership of 18,193,892 shares of Common Stock, representing 7.48% of the class as reported. The filing states Vanguard has sole dispositive power for 18,193,892 shares and sole voting power for 2,376,964 shares. The report is signed and dated 04/30/2026.
Xylem Inc. multiple Vanguard entities reported beneficial ownership of 12,800,726 shares of Common Stock, representing 5.26% of the class, on a Schedule 13G filing. The filing states Vanguard Portfolio Management LLC has sole dispositive power over 12,800,726 shares and sole voting power of 29,497 shares.
The filing explains these holdings reflect securities held across Vanguard funds and managed accounts for which Vanguard Portfolio Management LLC or affiliated business divisions exercise dispositive authority. The disclosure is signed by the Head of Global Fund Administration and dated 04/29/2026.
Xylem Inc. reported first-quarter 2026 revenue of $2,125 million, up 2.7% from $2,069 million a year earlier. Most of the increase came from favorable foreign currency of $65 million, while organic revenue slipped 0.4%.
Net income attributable to Xylem rose to $193 million from $169 million, with earnings per diluted share increasing to $0.79 from $0.69. Net margin improved to 9.1% and adjusted EBITDA margin edged up to 20.6%.
Water Infrastructure, Applied Water, and Measurement and Control Solutions all posted modest revenue growth, while Water Solutions and Services was roughly flat as weaker U.S. capital project activity and lower opening backlog offset strength in other areas. The company generated $108 million of operating cash flow and invested $90 million in capital expenditures, while also repurchasing 4.8 million shares for $595 million.
Xylem Inc. reported first-quarter 2026 revenue of $2,125 million, up 2.7% from $2,069 million a year earlier. Most of the increase came from favorable foreign currency of $65 million, while organic revenue slipped 0.4%.
Net income attributable to Xylem rose to $193 million from $169 million, with earnings per diluted share increasing to $0.79 from $0.69. Net margin improved to 9.1% and adjusted EBITDA margin edged up to 20.6%.
Water Infrastructure, Applied Water, and Measurement and Control Solutions all posted modest revenue growth, while Water Solutions and Services was roughly flat as weaker U.S. capital project activity and lower opening backlog offset strength in other areas. The company generated $108 million of operating cash flow and invested $90 million in capital expenditures, while also repurchasing 4.8 million shares for $595 million.
Xylem Inc. reported first-quarter 2026 revenue of $2.125 billion, up 3% year over year and flat on an organic basis. Net income attributable to Xylem was $193 million, or $0.79 per share, a 14% increase. Adjusted diluted EPS was $1.12, up 9%.
Net income margin rose to 9.1%, while adjusted EBITDA margin reached 20.6%, a 20 basis point improvement. Xylem now forecasts full-year 2026 revenue of $9.2–$9.3 billion, up about 2–3% on a reported basis, and maintains adjusted EPS guidance of $5.35–$5.60 and free cash flow margin of 10.2–11.0%.
Xylem Inc. reported first-quarter 2026 revenue of $2.125 billion, up 3% year over year and flat on an organic basis. Net income attributable to Xylem was $193 million, or $0.79 per share, a 14% increase. Adjusted diluted EPS was $1.12, up 9%.
Net income margin rose to 9.1%, while adjusted EBITDA margin reached 20.6%, a 20 basis point improvement. Xylem now forecasts full-year 2026 revenue of $9.2–$9.3 billion, up about 2–3% on a reported basis, and maintains adjusted EPS guidance of $5.35–$5.60 and free cash flow margin of 10.2–11.0%.
Xylem Inc. is asking shareholders to vote at its virtual 2026 Annual Meeting on May 14, 2026, while highlighting record 2025 performance and governance practices. Revenue reached $9.0 billion, up 6% reported and 5% organically, with net income margin of 10.6% and adjusted EBITDA margin of 22.2%.
EPS was $3.92 (GAAP) and $5.08 on an adjusted basis, supported by record orders over $8.9 billion and a $4.6 billion backlog. Xylem returned $391 million to shareholders via 2025 dividends and achieved the full $140 million Evoqua cost synergy run-rate one year ahead of target.
Shareholders will vote on electing nine directors, ratifying Deloitte & Touche LLP as auditor, approving named executive officer compensation, and implementing a new 2026 Employee Stock Purchase Plan covering up to 4,000,000 shares at a 15% discount to market. The Board recommends voting FOR all four proposals.